252 related articles for article (PubMed ID: 25535894)
1. Bioactive insulin-like growth factors as a possible molecular target for non-islet cell tumor hypoglycemia.
Setoyama T; Miyamoto S; Horimatsu T; Funakoshi T; Nikaido M; Kodama Y; Minamiguchi S; Yamabata T; Muto M; Chiba T
Cancer Biol Ther; 2014; 15(12):1588-92. PubMed ID: 25535894
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hypoglycemia using combined glucocorticoid and recombinant human growth hormone in a patient with a metastatic non-islet cell tumor hypoglycemia.
Bourcigaux N; Arnault-Ouary G; Christol R; Périn L; Charbonnel B; Le Bouc Y
Clin Ther; 2005 Feb; 27(2):246-51. PubMed ID: 15811488
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of the concentrations of IGFs and several IGF-binding proteins in a large fibrous abdominal tumor and the circulation of a patient with hypoglycemia.
van Doorn J; van de Hoef W; Dullaart RP
Biofactors; 2015 May; 41(3):183-9. PubMed ID: 26073062
[TBL] [Abstract][Full Text] [Related]
4. The effect of growth hormone treatment on the insulin-like growth factor axis in a child with nonislet cell tumor hypoglycemia.
Katz LE; Liu F; Baker B; Agus MS; Nunn SE; Hintz RL; Cohen P
J Clin Endocrinol Metab; 1996 Mar; 81(3):1141-6. PubMed ID: 8772589
[TBL] [Abstract][Full Text] [Related]
5. Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors.
Daughaday WH; Kapadia M
Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6778-82. PubMed ID: 2771956
[TBL] [Abstract][Full Text] [Related]
6. Hypoglycemia due to paraneoplastic secretion of insulin-like growth factor-I in a patient with metastasizing large-cell carcinoma of the lung.
Nauck MA; Reinecke M; Perren A; Frystyk J; Berishvili G; Zwimpfer C; Figge AM; Flyvbjerg A; Lankisch PG; Blum WF; Klöppel G; Schmiegel W; Zapf J
J Clin Endocrinol Metab; 2007 May; 92(5):1600-5. PubMed ID: 17299065
[TBL] [Abstract][Full Text] [Related]
7. Serum high molecular weight form of insulin-like growth factor II from patients with non-islet cell tumor hypoglycemia is O-glycosylated.
Hizuka N; Fukuda I; Takano K; Asakawa-Yasumoto K; Okubo Y; Demura H
J Clin Endocrinol Metab; 1998 Aug; 83(8):2875-7. PubMed ID: 9709962
[TBL] [Abstract][Full Text] [Related]
8. Instability of IGF-IGFBP complex as a cause of the different performance of serum and EDTA-plasma after storage: EDTA-plasma is preferable for evaluating bioactive IGF especially in the mouse.
Setoyama T; Miyamoto S; Nikaido M; Muto M; Chiba T
Growth Horm IGF Res; 2015 Oct; 25(5):227-31. PubMed ID: 26144570
[TBL] [Abstract][Full Text] [Related]
9. Characterization of insulin-like growth factor II (IGF-II) and IGF binding proteins in patients with non-islet-cell tumor hypoglycemia.
Fukuda I; Hizuka N; Takano K; Asakawa-Yasumoto K; Shizume K; Demura H
Endocr J; 1993 Feb; 40(1):111-9. PubMed ID: 7524924
[TBL] [Abstract][Full Text] [Related]
10. Levels of glucose-regulatory hormones in patients with non-islet cell tumor hypoglycemia: including a review of the literature.
Fukuda I; Asai A; Nagamine T; Harada T; Tanimura-Inagaki K; Hizuka N; Sugihara H
Endocr J; 2017 Jul; 64(7):719-726. PubMed ID: 28529277
[TBL] [Abstract][Full Text] [Related]
11. [Hypoglycemia associated with the production of insulin-like growth factor (IGF)-II by a hemangiopericytoma].
Plikat K; Reichle A; Elmlinger MW; Schölmerich J
Dtsch Med Wochenschr; 2003 Feb; 128(6):257-60. PubMed ID: 12571793
[TBL] [Abstract][Full Text] [Related]
12. Gene expression and serum levels of insulin-like growth factors (IGFs) and IGF-binding proteins in a case of non-islet cell tumour hypoglycaemia.
Holt RI; Teale JD; Jones JS; Quin JD; McGregor AM; Miell JP
Growth Horm IGF Res; 1998 Dec; 8(6):447-54. PubMed ID: 10985756
[TBL] [Abstract][Full Text] [Related]
13. A Rare Diagnosis After the Fall of a 96-Year-Old Woman: Doege-Potter Syndrome.
Pincelli AI; Perotti M; Massariello F; Gatti A; Calella D; Cimino V; Haas J; Bellelli G; Mazzola P; Annoni G
Curr Aging Sci; 2018; 11(3):195-200. PubMed ID: 30520387
[TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic Hypoglycemia Leading to Insulin Independence in a Patient With Type 1 Diabetes.
Haeri NS; Mahmud H; Korytkowski MT
AACE Clin Case Rep; 2021; 7(6):376-378. PubMed ID: 34765735
[TBL] [Abstract][Full Text] [Related]
15. The role of insulin-like growth factors and their binding proteins in tumor hypoglycemia.
Baxter RC
Horm Res; 1996; 46(4-5):195-201. PubMed ID: 8950621
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of circulating free insulin-like growth factors in patients with non-islet cell tumour hypoglycaemia.
Frystyk J; Skjaerbaek C; Zapf J; Orskov H
Diabetologia; 1998 May; 41(5):589-94. PubMed ID: 9628278
[TBL] [Abstract][Full Text] [Related]
17. Hypoglycemia mediated by paraneoplastic production of Insulin like growth factor-2 from a malignant renal solitary fibrous tumor - clinical case and literature review.
Khowaja A; Johnson-Rabbett B; Bantle J; Moheet A
BMC Endocr Disord; 2014 Jun; 14():49. PubMed ID: 24934576
[TBL] [Abstract][Full Text] [Related]
18. Serum insulin-like growth factor II in 44 patients with non-islet cell tumor hypoglycemia.
Hizuka N; Fukuda I; Takano K; Okubo Y; Asakawa-Yasumoto K; Demura H
Endocr J; 1998 Apr; 45 Suppl():S61-5. PubMed ID: 9790231
[TBL] [Abstract][Full Text] [Related]
19. Serum "big insulin-like growth factor II" from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing.
Daughaday WH; Trivedi B; Baxter RC
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5823-7. PubMed ID: 7685912
[TBL] [Abstract][Full Text] [Related]
20. Alterations of the 11p15 imprinted region and the IGFs system in a case of recurrent non-islet-cell tumour hypoglycaemia (NICTH).
Bertherat J; Logié A; Gicquel C; Mourriéras F; Luton JP; Le Bouc Y
Clin Endocrinol (Oxf); 2000 Aug; 53(2):213-20. PubMed ID: 10931103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
